USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
13THERAPEUTICS, INC.
Address:
2611 SW 3RD AVE, STE 200
PORTLAND, OR 97201-4952
Phone:
N/A
URL:
N/A
EIN:
193122655
DUNS:
32263092
Number of Employees:
N/A
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase II $2,995,281.00 1

Award List:

Bacterial-Induced Sepsis: A New Treatment Strategy

Award Year / Program / Phase:
2011 / SBIR / Phase II
Award Amount:
$2,995,281.00
Agency:
HHS
Principal Investigator:
Sharon L. Mccoy – 503-525-4884
Abstract:
DESCRIPTION (provided by applicant): Sepsis is a prevalent and life-threatening medical condition characterized by development of a dysregulated inflammatory immune response and associated tissue damage. This dysregulated inflammatory response is initiatedby activation of Toll-Like receptor (TLR)… More